BROWN AND BURK UK LIMITED — Ramipril Importer Profile
Pharmaceutical Importer · #4 buyer for Ramipril · $3.9M import value · 143 shipments · UNITED KINGDOM · DGFT Verified
BROWN AND BURK UK LIMITED is the #4 importer of Ramipril from India with $3.9M in import value and 143 verified shipments. BROWN AND BURK UK LIMITED holds a 4.4% market share in Ramipril imports based in UNITED KINGDOM. The company sources from 1 verified supplier across 72 formulations shipped to 1 country. Overall, BROWN AND BURK UK LIMITED imports 6 pharmaceutical products worth $16.5M across 5 therapeutic categories.
BROWN AND BURK UK LIMITED — Ramipril Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ramipril to BROWN AND BURK UK LIMITED?
Verified from 143 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MICRO LABS LIMITED | $3.9M | 143 | 100.0% |
BROWN AND BURK UK LIMITED sources Ramipril from 1 verified Indian supplier based on 143 customs records. The primary supplier is MICRO LABS LIMITED accounting for 100.0% of imports.
How Does BROWN AND BURK UK LIMITED Compare to Nearest Ramipril Importers?
Buyers ranked immediately above and below #4 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | WOCKHARDT UK LIMITED | UNITED KINGDOM | $6.7M | 276 | $24.2K |
| 3 | CRESCENT PHARMA LTD | UNITED KINGDOM | $5.8M | 191 | $30.2K |
| 4 | BROWN AND BURK UK LIMITED ★ | UNITED KINGDOM | $4.0M | 125 | $31.8K |
| 6 | ZENTIVA ITALIA SRL | ITALY | $3.8M | 169 | $22.8K |
| 8 | M/S CRESCENT PHARMA LTD. | UNITED KINGDOM | $3.1M | 208 | $14.8K |
BROWN AND BURK UK LIMITED ranks #4 among 389 Ramipril importers from India. Average shipment value of $31.8K compared to the market average of $102.1K. The closest competitors by value are WOCKHARDT UK LIMITED and CRESCENT PHARMA LTD.
Where Does BROWN AND BURK UK LIMITED Import Ramipril To?
Destination countries from 143 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $3.9M | 143 | 100.0% |
BROWN AND BURK UK LIMITED imports Ramipril to 1 country. The primary destination is UNITED KINGDOM receiving 100.0% of shipments worth $3.9M.
What Ramipril Formulations Does BROWN AND BURK UK LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| RAMIPRIL 2.5 MG CAPSULES (IN BB LIVERY) | $521.9K | 15 |
| RAMIPRIL 2.5mg CAPSULES ( (IN BB LIVERY) | $178.6K | 10 |
| RAMIPRIL 5MG CAPSULES IN BB LIVERY PA | $150.0K | 5 |
| RAMIPRIL 10MG CAPSULES (IN BB LIVERY) (P | $147.5K | 4 |
| RAMIPRIL 5MG CAPSULES (IN BB LIVERY) (PA | $139.6K | 4 |
| RAMIPRIL 10MG CAPSULES (IN BB LIVERY) PA | $124.4K | 3 |
| RAMIPRIL 1.25mg CAPSULES (IN BB LIVERY) | $119.6K | 4 |
| RAMIPRIL 10mg CAPSULES ( (BB LIVERY) ) ( | $111.0K | 3 |
| RAMIPRIL 1.25mg CAPSULES ( (IN BB LIVERY | $105.4K | 3 |
| RAMIPRIL 10MG CAPSULES ( (IN BB LIVERY) | $100.0K | 2 |
BROWN AND BURK UK LIMITED imports 72 distinct Ramipril formulations from India. The top formulation is RAMIPRIL 2.5 MG CAPSULES (IN BB LIVERY) with 15 shipments worth $521.9K.
Regulatory Requirements: Importing Ramipril into United Kingdom
What BROWN AND BURK UK LIMITED and other importers must comply with to import Ramipril from India
Regulatory Authority
Medicines and Healthcare products Regulatory Agency (MHRA)
Approval Process for Generic Ramipril
Marketing Authorisation via national procedure or Mutual Recognition. Post-Brexit, separate UK MA required independent of EU approval.
Typical timeline: 12–15 months for national procedure
GMP Requirements
UK GMP compliance; MHRA GMP inspection of manufacturing site
Import Licence & Documentation
Manufacturer/Importer Authorisation (MIA) from MHRA; Qualified Person release required
Labeling & Packaging
UK-specific labeling; English language PIL; UK Marketing Authorisation number
Note: Post-Brexit, EU GMP certificates no longer automatically valid — separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available MHRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with MHRA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Ramipril from India and How Much Does BROWN AND BURK UK LIMITED Import?
India exported $39.7M worth of Ramipril through 4,977 shipments from 177 suppliers to 93 countries, serving 389 buyers globally. BROWN AND BURK UK LIMITED imports $3.9M of this total, accounting for 4.4% of India's Ramipril exports with 143 shipments from UNITED KINGDOM. This is verified from 143 customs shipment records covering 72 distinct formulations.
What Is the Average Order Value for BROWN AND BURK UK LIMITED's Ramipril Imports?
BROWN AND BURK UK LIMITED's average Ramipril order value is $27.3K per consignment, based on 143 shipments totaling $3.9M. BROWN AND BURK UK LIMITED is based in UNITED KINGDOM and ranks #4 among all Ramipril importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Ramipril to BROWN AND BURK UK LIMITED?
BROWN AND BURK UK LIMITED sources Ramipril from 1 verified Indian supplier: MICRO LABS LIMITED ($3.9M, 100.0%). This is based on 143 customs records.
How Does BROWN AND BURK UK LIMITED Compare to Other Ramipril Importers?
BROWN AND BURK UK LIMITED ranks #4 among 389 Ramipril importers from India with a 4.4% market share. The top 3 importers are WOCKHARDT UK LIMITED ($6.7M), CRESCENT PHARMA LTD ($5.8M), BROWN AND BURK UK LIMITED ($4.0M). BROWN AND BURK UK LIMITED processed 143 shipments from UNITED KINGDOM.
What Other Cardiovascular Products Does BROWN AND BURK UK LIMITED Import?
BROWN AND BURK UK LIMITED also imports these cardiovascular products. Each links to the detailed product page.
About BROWN AND BURK UK LIMITED
BROWN AND BURK UK LIMITED imports 6 products worth $16.5M. Beyond Ramipril, top products include Gabapentin, Flucloxacillin, Clarithromycin, Lisinopril, Vati. View the complete BROWN AND BURK UK LIMITED profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ramipril — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ramipril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: BROWN AND BURK UK LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as BROWN AND BURK UK LIMITED's capped import value divided by total capped export value for Ramipril across all Indian exporters.
- 5.Verified Records: This page is backed by 143 individual customs records matching BROWN AND BURK UK LIMITED importing Ramipril, covering 72 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 93+ countries, 389+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ramipril Import Data for BROWN AND BURK UK LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for BROWN AND BURK UK LIMITED's Ramipril imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BROWN AND BURK UK LIMITED
Full Company Profile →
6 products · $16.5M total trade · 5 categories
BROWN AND BURK UK LIMITED × Ramipril
Verified from customs records
Company Overview
Top Products by BROWN AND BURK UK LIMITED
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for BROWN AND BURK UK LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ramipril. For current order-level data, contact TransData Nexus.